Skip to main content
NCBI home page
Journal of Athletic Training logoLink to Journal of Athletic Training
. 1999 Oct-Dec;34(4):338–341.

Serum Dexamethasone Levels After Decadron Phonophoresis

Heather Darrow *, Shane Schulthies *, David Draper *, Mark Ricard *, Gary J Measom †
PMCID: PMC1323341  PMID: 16558583

Abstract

Objective:

To determine serum levels of dexamethasone at several intervals after administration of Decadron (dexamethasone sodium phosphate) phonophoresis.

Design and Setting:

This study was designed as a 2-factor analysis of variance with repeated measures on 1 factor (blood draws). Independent variables were group (gel/sham, gel/ ultrasound, dexamethasone/sham, dexamethasone/ultrasound) and blood draws (pretreatment, posttreatment, 15 minutes, and 30 minutes). The dependent variable was the serum level of dexamethasone.

Subjects:

Forty healthy college students (21 males, 19 females; mean age = 22 ± 1.3 years) with no known drug allergies or current medication use were randomly assigned to 1 of 4 treatment groups. The treatment site was the left forearm.

Measurements:

After the pretreatment blood draw, a 10- minute ultrasound treatment was administered, followed by a posttreatment blood draw. Two additional blood draws followed at 15-minute intervals. A total of 4 serum samples (5 cc each) from each subject were centrifuged, and the pipetted serum was frozen for later analysis by double antibody radioimmunoassay.

Results:

No significant amounts of serum dexamethasone were detected in 12 consecutive samples. Testing of additional samples was, therefore, discontinued.

Conclusions:

Decadron phonophoresis as used in this experiment did not result in detectable serum levels of dexamethasone. More study is needed to validate the efficacy of Decadron phonophoresis on serum dexamethasone levels.

Keywords: corticosteroid, ultrasound, serum analysis

Full text

PDF
338

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bare A. C., McAnaw M. B., Pritchard A. E., Struebing J. G., Smutok M. A., Christie D. S., Domenech M. A., Bare M. A., Bloodworth M. L., Seal L. A. Phonophoretic delivery of 10% hydrocortisone through the epidermis of humans as determined by serum cortisol concentrations. Phys Ther. 1996 Jul;76(7):738–749. doi: 10.1093/ptj/76.7.738. [DOI] [PubMed] [Google Scholar]
  2. Benson H. A., McElnay J. C., Harland R. Use of ultrasound to enhance percutaneous absorption of benzydamine. Phys Ther. 1989 Feb;69(2):113–118. doi: 10.1093/ptj/69.2.113. [DOI] [PubMed] [Google Scholar]
  3. Bommannan D., Menon G. K., Okuyama H., Elias P. M., Guy R. H. Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm Res. 1992 Aug;9(8):1043–1047. doi: 10.1023/a:1015806528336. [DOI] [PubMed] [Google Scholar]
  4. Bommannan D., Okuyama H., Stauffer P., Guy R. H. Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery. Pharm Res. 1992 Apr;9(4):559–564. doi: 10.1023/a:1015808917491. [DOI] [PubMed] [Google Scholar]
  5. Byl N. N., McKenzie A., Halliday B., Wong T., O'Connell J. The effects of phonophoresis with corticosteroids: a controlled pilot study. J Orthop Sports Phys Ther. 1993 Nov;18(5):590–600. doi: 10.2519/jospt.1993.18.5.590. [DOI] [PubMed] [Google Scholar]
  6. Cameron M. H., Monroe L. G. Relative transmission of ultrasound by media customarily used for phonophoresis. Phys Ther. 1992 Feb;72(2):142–148. doi: 10.1093/ptj/72.2.142. [DOI] [PubMed] [Google Scholar]
  7. Davick J. P., Martin R. K., Albright J. P. Distribution and deposition of tritiated cortisol using phonophoresis. Phys Ther. 1988 Nov;68(11):1672–1675. doi: 10.1093/ptj/68.11.1672. [DOI] [PubMed] [Google Scholar]
  8. GRIFFIN J. E., TOUCHSTONE J. C., LIU A. C. ULTRASONIC MOVEMENT OF CORTISOL INTO PIG TISSUE. II. MOVEMENT INTO PARAVERTEBRAL NERVE. Am J Phys Med. 1965 Feb;44:20–25. [PubMed] [Google Scholar]
  9. GRIFFIN J. E., TOUCHSTONE J. C. Ultrasonic movement of cortisol into pig tissues. I. Movement into skeletal muscle. Am J Phys Med. 1963 Apr;42:77–85. [PubMed] [Google Scholar]
  10. Griffin J. E., Echternach J. L., Price R. E., Touchstone J. C. Patients treated with ultrasonic driven hydrocortisone and with ultrasound alone. Phys Ther. 1967 Jul;47(7):594–601. doi: 10.1093/ptj/47.7.594. [DOI] [PubMed] [Google Scholar]
  11. Griffin J. E., Touchstone J. C. Effects of ultrasonic frequency on phonophoresis of cortisol into swine tissues. Am J Phys Med. 1972 Apr;51(2):62–78. [PubMed] [Google Scholar]
  12. Griffin J. E., Touchstone J. C. Low-intensity phonophoresis of cortisol in swine. Phys Ther. 1968 Dec;48(12):1336–1344. doi: 10.1093/ptj/48.12.1336. [DOI] [PubMed] [Google Scholar]
  13. Kleinkort J. A., Wood F. Phonophoresis with 1 percent versus 10 percent hydrocortisone. Phys Ther. 1975 Dec;55(12):1320–1324. doi: 10.1093/ptj/55.12.1320. [DOI] [PubMed] [Google Scholar]
  14. Meikle A. W., Lagerquist L. G., Tyler F. H. A plasma dexamethasone radioimmunoassay. Steroids. 1973 Aug;22(2):193–202. doi: 10.1016/0039-128x(73)90085-8. [DOI] [PubMed] [Google Scholar]
  15. Mitragotri S., Blankschtein D., Langer R. Ultrasound-mediated transdermal protein delivery. Science. 1995 Aug 11;269(5225):850–853. doi: 10.1126/science.7638603. [DOI] [PubMed] [Google Scholar]
  16. Mitragotri S., Edwards D. A., Blankschtein D., Langer R. A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci. 1995 Jun;84(6):697–706. doi: 10.1002/jps.2600840607. [DOI] [PubMed] [Google Scholar]
  17. Oziomek R. S., Perrin D. H., Herold D. A., Denegar C. R. Effect of phonophoresis on serum salicylate levels. Med Sci Sports Exerc. 1991 Apr;23(4):397–401. [PubMed] [Google Scholar]
  19. Wing M. Phonophoresis with hydrocortisone in the treatment of temporomandibular joint dysfunction. Phys Ther. 1982 Jan;62(1):32–33. doi: 10.1093/ptj/62.1.32. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Athletic Training are provided here courtesy of National Athletic Trainers Association

RESOURCES